Nextcure Stock Investor Sentiment
| NXTC Stock | USD 5.04 0.15 3.07% |
About 73 percent of all NextCure's shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding NextCure suggests that quite a large number of traders are confidant. The current market sentiment, together with NextCure's historical and current headlines, can help investors time the market. In addition, many technical investors use NextCure stock news signals to limit their universe of possible portfolio assets.
Comfort Level 73
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use NextCure's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward NextCure.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentAcquiring |
NextCure Historical Sentiment
Although NextCure's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding NextCure, such as negative comments on social media and news outlets, may cause fear in the market and push NextCure's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of NextCure.
NextCure Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards NextCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
NextCure Historical Investor Sentiment
Investor biases related to NextCure's public news can be used to forecast risks associated with an investment in NextCure. The trend in average sentiment can be used to explain how an investor holding NextCure can time the market purely based on public headlines and social activities around NextCure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
NextCure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for NextCure and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average NextCure news discussions. The higher the estimate score, the more favorable the investor's outlook on NextCure.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of NextCure's Stock prices. Below is the latest headlines and news related to NextCure Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about NextCure that are available to investors today. This information is accessible both publicly - through NextCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of NextCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of NextCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NextCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NextCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NextCure alpha.
NextCure Largest EPS Surprises
Earnings surprises can significantly impact NextCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-03-19 | 2024-12-31 | -0.36 | -0.41 | -0.05 | 13 | ||
2021-03-04 | 2020-12-31 | -0.6 | -0.54 | 0.06 | 10 | ||
2024-11-04 | 2024-09-30 | -0.34 | -0.41 | -0.07 | 20 | ||
2022-05-05 | 2022-03-31 | -0.67 | -0.74 | -0.07 | 10 | ||
2020-03-12 | 2019-12-31 | -0.45 | -0.34 | 0.11 | 24 | ||
2024-05-02 | 2024-03-31 | -0.46 | -0.61 | -0.15 | 32 |
There is far too much social signal, news, headlines, and media speculation about NextCure that are available to investors today. This information is accessible both publicly - through NextCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of NextCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of NextCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NextCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NextCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NextCure alpha.
NextCure Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Jones Elaine V of 18700 shares of NextCure at 1.5 subject to Rule 16b-3 | 06/02/2025 |
2 | Acquisition by Myint Han of 103600 shares of NextCure at 5.57 subject to Rule 16b-3 | 06/06/2025 |
3 | NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate ... | 06/16/2025 |
4 | Acquisition by Feigal Ellen of 18700 shares of NextCure at 0.47 subject to Rule 16b-3 | 06/20/2025 |
5 | Acquisition by Jones Elaine V of 14250 shares of NextCure at 8.21 subject to Rule 16b-3 | 06/27/2025 |
6 | NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks | 07/10/2025 |
7 | NextCure Price Target Cut by Piper Sandler NXTC Stock News | 07/15/2025 |
8 | Acquisition by Richman Michael of 305500 shares of NextCure at 0.8048 subject to Rule 16b-3 | 07/18/2025 |
9 | NextCure Given a 15.00 Price Target at Piper Sandler | 07/23/2025 |
10 | NextCure Reveals Promising Preclinical Data for Osteogenesis Imperfecta Treatment NXTC ... | 07/24/2025 |
11 | NextCure Price Target Cut to 15.00 by Analysts at Piper Sandler | 07/29/2025 |
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |